Clinical Trial Update: Effects of Non-Specific Endothelin-A Receptor Blockade on Ocular Blood Flow in Patients With Glaucoma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the effects of a non-specific endothelin-A receptor blocker on ocular blood flow in patients with glaucoma. The study status i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma

Drugs mentioned

• Non-specific endothelin-A receptor blocker

Snippet

Sponsor: Medical University of Vienna | Conditions: Glaucoma, Blood Flow Velocity | Phase 1 | Status: COMPLETED